Effect of Colchicine on MMP-9, NOX2, and TGF-β1 in Myocardial Infarct
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 148 participants.
Also called NCT05709509
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 148 participants
- Sponsor
- RSD dr. Soebandi
- Registry
-
NCT05709509
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Indonesia
- Registry status
- Unknown status
Technical summary
Registry record NCT05709509. Randomized; no masking; primary purpose treatment. Start 2022-06-01 (actual); primary completion 2023-05-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of Colchicine on MMP-9, NOX2, and TGF-β1 in Myocardial Infarct
- Condition
- ST Elevation Myocardial Infarction
- Condition
- Colchicine
- Condition
- Cardiac Remodeling, Ventricular
- Intervention (Drug)
- Colchicine
- Intervention (Procedure)
- Percutaneous Coronary Intervention
- Intervention (Other)
- Optimal medical treatment including statin, aspirin, P2Y12 inhibitor, and nitrate.
- Lead sponsor
- RSD dr. Soebandi
- Collaborator
- Universitas Jember
- Collaborator
- University of Brawijaya
Record details
- Record id
cardio:ct-nct05709509- Content hash
8699e4e663272c909e39441125391f589184c20d6b753bff0025fbbef0acc110